Forecast came true

Valeant Pharmaceuticals (VRX) Will Go Up After its Earnings Report
31 july

Valeant Pharmaceuticals (VRX) reports results on Aug. 8 BMO. The stock is dipping ahead of results.

VRX stock pulled back from the $18 top, trading at below $16.25 today:


VRX, VALEANT PHARMACEUTICALS INTERNATIONAL

But given the debt cut and improving business, the stock could go up after the ER.

Related: TEVA, ENDP, MYL are generic drug suppliers to watch too. TEVA reports results later this week.

* *

Agree or disagree? Login now via StockTwits to vote. 

* *

Answered:
24 people

Valeant Pharmaceuticals (VRX) Will Go Up After its Earnings Report

Agreed
21 people
Disagreed
3 people

Forecast came true

Almost up +10% premarket and around 4-5% on the day.